Literature DB >> 8285761

Patent ductus arteriosus in the newborn.

N Archer1.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8285761      PMCID： PMC1029601          DOI： 10.1136/adc.69.5_spec_no.529

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  39 in total

1.  Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants.

Authors:  E F Bell; D Warburton; B S Stonestreet; W Oh
Journal:  N Engl J Med       Date:  1980-03-13       Impact factor: 91.245

2.  Indomethacin and renal function in premature infants with persistent patent ductus arteriosus.

Authors:  R F Cifuentes; P M Olley; J W Balfe; I C Radde; S J Soldin
Journal:  J Pediatr       Date:  1979-10       Impact factor: 4.406

3.  Persistent ductus arteriosus complicating the respiratory distress syndrome.

Authors:  R W Jones; D Pickering
Journal:  Arch Dis Child       Date:  1977-04       Impact factor: 3.791

4.  Echocardiographic characteristics of premature infants with patient ductus arteriosus.

Authors:  G L Johnson; G L Breart; M H Gewitz; J I Brenner; P Lang; K J Dooley; R C Ellison
Journal:  Pediatrics       Date:  1983-12       Impact factor: 7.124

5.  Digoxin therapy and left ventricular performance in premature infants with patent ductus arteriosus.

Authors:  B P Lundell; L O Boréus
Journal:  Acta Paediatr Scand       Date:  1983-05

6.  The silent ductus arteriosus in idiopathic respiratory distress syndrome.

Authors:  L N Archer; E J Glass; M J Godman
Journal:  Acta Paediatr Scand       Date:  1984-09

7.  Indomethacin therapy on the first day of life in infants with very low birth weight.

Authors:  L Mahony; R L Caldwell; D A Girod; R A Hurwitz; R D Jansen; J A Lemons; R L Schreiner
Journal:  J Pediatr       Date:  1985-05       Impact factor: 4.406

8.  Evaluation of the preterm infant for patent ductus arteriosus.

Authors:  R C Ellison; G J Peckham; P Lang; N S Talner; T J Lerer; L Lin; K J Dooley; A S Nadas
Journal:  Pediatrics       Date:  1983-03       Impact factor: 7.124

9.  Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.

Authors:  W M Gersony; G J Peckham; R C Ellison; O S Miettinen; A S Nadas
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

10.  Digoxin therapy in low-birth-weight infants with patent ductus arteriosus.

Authors:  W Berman; O Dubynsky; V Whitman; Z Friedman; M J Maisels
Journal:  J Pediatr       Date:  1978-10       Impact factor: 4.406
View more
  6 in total

1.  Clinical profile and management of PDA in neonates.

Authors:  C C Shanthala; P P Maiya; D Vishwanath; N Banakappa; P M Swamy; N Desai; K H Srinivas
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

2.  Drug induced closure of patent ductus arteriosus.

Authors:  N Archer
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

3.  Stenting the arterial duct.

Authors:  J L Gibbs
Journal:  Arch Dis Child       Date:  1995-03       Impact factor: 3.791

4.  Patent ductus arteriosus in the newborn.

Authors:  G Hartnoll; P Betremieux; N Modi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-05       Impact factor: 5.747

5.  Catheter closure of the arterial duct in preterm infants.

Authors:  Philip Roberts; Satish Adwani; Nick Archer; Neil Wilson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-08-18       Impact factor: 5.747

6.  Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis.

Authors:  Lleona C L Lee; Angela Tillett; Robert Tulloh; Robert Yates; Wilf Kelsall
Journal:  BMC Pediatr       Date:  2006-05-11       Impact factor: 2.125
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.